CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,689 | -5.5% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,788 | +30.8% | 55,000 | +25.0% | 0.00% | +33.3% |
| Q1 2023 | $1,367 | -45.6% | 44,000 | -21.6% | 0.00% | -57.1% |
| Q4 2022 | $2,515 | -99.9% | 56,100 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $2,724,000 | +16.2% | 56,100 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $2,345,000 | +14.4% | 56,100 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $2,049,000 | -12.8% | 56,100 | +10.0% | 0.01% | -16.7% |
| Q4 2021 | $2,349,000 | +41.9% | 51,000 | +2.8% | 0.01% | +20.0% |
| Q3 2021 | $1,655,000 | +222.6% | 49,600 | +101.6% | 0.01% | +400.0% |
| Q2 2021 | $513,000 | -5.7% | 24,600 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $544,000 | +7.7% | 24,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $505,000 | -71.5% | 24,600 | -69.6% | 0.00% | -75.0% |
| Q3 2020 | $1,772,000 | – | 80,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |